Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ADMA ADMA Biologics Inc | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $9.11 +1.8% | $15.06 -2.0% |
| StockIQ Score | 49D+ Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 32F | 13F |
| Fundamental | 83A- | 35F |
| Growth | 37F | 50C- |
| Fair Value | 38F | 38F |
| News | 38F | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 62C+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
ADMA Biologics shows stronger fundamentals (83 vs. 35) and technicals (59 vs. 18), making it the better-performing stock in those areas. However, Ascentage Pharma has higher growth potential (50 vs. 37) and equal valuation (38 vs. 38). ADMA’s overall rating is "Moderate," while Ascentage’s is "Weak."